{"id":173297,"date":"2012-10-09T15:51:16","date_gmt":"2012-10-09T19:51:16","guid":{"rendered":"https:\/\/yfiledev.uit.yorku.ca\/?p=173297"},"modified":"2025-04-02T09:31:13","modified_gmt":"2025-04-02T13:31:13","slug":"york-study-finds-health-canadas-fast-tracked-drug-approvals-can-put-public-at-risk","status":"publish","type":"post","link":"https:\/\/www.yorku.ca\/yfile\/2012\/10\/09\/york-study-finds-health-canadas-fast-tracked-drug-approvals-can-put-public-at-risk\/","title":{"rendered":"York study finds Health Canada's fast-tracked drug approvals can put public at risk"},"content":{"rendered":"
Drugs streamed into Health Canada\u2019s accelerated review process are more likely to be withdrawn from the market or earn a serious safety warning than those that undergo the standard review, according to a recent paper out of ¿ì²¥ÊÓÆµ.<\/div>\n